We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ADXN market cap is 987.32M. The company's latest EPS is CHF -0.2697 and P/E is -3.67.
Quarter End | |||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | |||||
Operating Income | |||||
Net Income |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Revenue | 6.04M | 2.76M | 3.61M | 2.92M | 1.42M |
Operating Income | -1.43M | -14.6M | -12.24M | -15.51M | -20.52M |
Net Income | -1.65M | -14.78M | -12.86M | -15.35M | -20.8M |
Quarter End | |||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | |||||
Total Liabilities | |||||
Total Equity |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Total Assets | 42.21M | 33.03M | 20.18M | 22.54M | 8.28M |
Total Liabilities | 2.97M | 7.51M | 5.57M | 5.61M | 3.37M |
Total Equity | 39.24M | 25.52M | 14.61M | 16.93M | 4.91M |
Quarter End | |||||
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | |||||
Investing | |||||
Financing |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | CHF (CHF) | |
Operating | 1.75M | -9.48M | -12.18M | -14.71M | -16.44M |
Investing | -61k | -43k | -59k | -30k | 3k |
Financing | 37.39M | -464k | 46k | 16.4M | 3.1M |
Market Cap | 987.32M |
Price to Earnings Ratio | -3.67 |
Price to Sales Ratio | 53.8 |
Price to Cash Ratio | 10.98 |
Price to Book Ratio | 15.54 |
Dividend Yield | - |
Shares Outstanding | 77.13M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 1.27 (9.77%) |
Company Name | Addex Therapeutics Ltd |
Address |
12 chemin des aulx geneva 1228 |
Website | https://www.addextherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions